Literature DB >> 12324561

COX inhibitors and thromboregulation.

Aaron J Marcus1, M Johan Broekman, David J Pinsky.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12324561     DOI： 10.1056/NEJMcibr021805

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

Review 1.  Success of prostaglandin E2 in structure-function is a challenge for structure-based therapeutics.

Authors:  Charles N Serhan; Bruce Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-14       Impact factor: 11.205

2.  Glucose and collagen regulate human platelet activity through aldose reductase induction of thromboxane.

Authors:  Wai Ho Tang; Jeremiah Stitham; Scott Gleim; Concetta Di Febbo; Ettore Porreca; Cristiano Fava; Stefania Tacconelli; Marta Capone; Virgilio Evangelista; Giacomo Levantesi; Li Wen; Kathleen Martin; Pietro Minuz; Jeffrey Rade; Paola Patrignani; John Hwa
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

3.  Metabolomics: building on a century of biochemistry to guide human health.

Authors:  J Bruce German; Bruce D Hammock; Steven M Watkins
Journal:  Metabolomics       Date:  2005-03       Impact factor: 4.290

Review 4.  Which anti-platelet therapies might be beneficial in xenotransplantation?

Authors:  Moritz Schmelzle; Peter J Cowan; Simon C Robson
Journal:  Xenotransplantation       Date:  2011 Mar-Apr       Impact factor: 3.907

5.  Laser-induced endothelial cell activation supports fibrin formation.

Authors:  Ben T Atkinson; Reema Jasuja; Vivien M Chen; Prathima Nandivada; Bruce Furie; Barbara C Furie
Journal:  Blood       Date:  2010-07-30       Impact factor: 22.113

6.  The efficacy of parecoxib on systemic inflammatory response associated with cardiopulmonary bypass during cardiac surgery.

Authors:  Qingping Wu; Gunsham Purusram; Huiqing Wang; Ruixia Yuan; Wanli Xie; Ping Gui; Nianguo Dong; Shanglong Yao
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

Review 7.  Dynamic and structural formation of a thrombus: the inciting event of arterial ischemic stroke.

Authors:  M Patricia Massicotte; M E Bauman
Journal:  J Child Neurol       Date:  2011-05-31       Impact factor: 1.987

8.  Ectonucleotidase tri(di)phosphohydrolase-1 (ENTPD-1) disrupts inflammasome/interleukin 1β-driven venous thrombosis.

Authors:  Vinita Yadav; Liguo Chi; Raymond Zhao; Benjamin E Tourdot; Srilakshmi Yalavarthi; Benjamin N Jacobs; Alison Banka; Hui Liao; Sharon Koonse; Anuli C Anyanwu; Scott H Visovatti; Michael A Holinstat; J Michelle Kahlenberg; Jason S Knight; David J Pinsky; Yogendra Kanthi
Journal:  J Clin Invest       Date:  2019-04-16       Impact factor: 14.808

9.  Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial.

Authors:  Nan Chiang; Edmund A Bermudez; Paul M Ridker; Shelley Hurwitz; Charles N Serhan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-07       Impact factor: 11.205

10.  Syntaxin-binding protein STXBP5 inhibits endothelial exocytosis and promotes platelet secretion.

Authors:  Qiuyu Zhu; Munekazu Yamakuchi; Sara Ture; Maria de la Luz Garcia-Hernandez; Kyung Ae Ko; Kristina L Modjeski; Michael B LoMonaco; Andrew D Johnson; Christopher J O'Donnell; Yoshimi Takai; Craig N Morrell; Charles J Lowenstein
Journal:  J Clin Invest       Date:  2014-09-17       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.